secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEPHROS INC (NEPH)
CIK:        0001196298
Form:       8-K
Filed at:   2022-01-13T23:59:59+00:00
Accession:  0001493152-22-001104
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nephros reports record FY2021 revenue of $10.4M, guides FY2022 $13-13.5M
------------------------------------------------------------------------

- Preliminary FY2021 net revenue $10.4M (+21% YoY); Q4 revenue $2.8M (+18% YoY).
- Issued FY2022 revenue guidance of $13.0M to $13.5M, representing 25-30% growth.
- Ended Q4 2021 with ~$7M cash; reinstated revenue guidance practice.
- Pathogen Detection Systems revenue $188k in 2021; expects >200% growth in 2022.
- Subsidiary SRP received FDA info request for HDF Assist; expects 510(k) clearance H1 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1196298/000149315222001104/0001493152-22-001104-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1196298/000149315222001104/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-001104

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer